CVS

CVS HEALTH CORP

12 superinvestors own CVS

Based on latest 13F filings — data is 45–90 days delayed

Investor	Fund	Weight	Shares	Value	Quarter	Activity
Prem Watsa	Fairfax Financial Holdings	10.33%	2,712,000	$215.2M	2025Q4	New
Christopher Davis	Davis Selected Advisers	4.55%	12,760,511	$1.0B	2025Q4	Added
Samantha McLemore	Patient Capital Management	3.77%	1,231,416	$97.7M	2025Q4	Reduced
Richard Pzena	Pzena Investment Management	3.70%	15,581,307	$1.2B	2025Q4	Reduced
Hillman Capital Management	Hillman Value Fund	3.58%	71,685	$5.7M	2025Q4	Reduced
Dodge & Cox	Dodge & Cox	2.68%	62,509,988	$5.0B	2025Q4	Reduced
Robert Olstein	Olstein Capital Management	0.91%	56,000	$4K	2025Q4	New
Ariel Investments	Ariel Investments (Bobrinskoy & Rogers)	0.71%	825,092	$65.5M	2025Q4	New
Tweedy Browne Co.	Tweedy Browne Value Fund	0.08%	12,085	$959K	2025Q4	Added
Bill Nygren	Oakmark Select Fund – Harris Associates	0.05%	525,051	$41.7M	2025Q4	Reduced
David Katz	Matrix Asset Advisors	0.04%	6,175	$490K	2025Q4	Held
Kenneth Fisher	Fisher Asset Management	0.00%	92,390	$7.3M	2025Q4	Added

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

What Is SEC Form 4?

Understand the insider trade filings behind CVS activity.

What Is a 13F Filing?

How superinvestors disclose their quarterly holdings.

Insider Cluster Buying

Why multiple insiders buying together is a strong signal.

Superinvestor Consensus

The most widely held stocks across all tracked institutions.